Status:
TERMINATED
Energy Expenditure and Body Composition in Pseudohypoparathyroidism 1a
Lead Sponsor:
Children's Hospital of Philadelphia
Conditions:
Pseudohypoparathyroidism Type 1A
Albright Hereditary Osteodystrophy
Eligibility:
All Genders
5-45 years
Brief Summary
The investigators would like to learn more about the metabolic consequences of pseudohypoparathyroidism type 1a in children, adolescents and adults with this condition. People with pseudohypoparathyro...
Detailed Description
Pseudohypoparathyroidism 1a (PHP1a) is a disorder that is associated with many endocrine problems. People with PHP1a are at risk for the development of obesity. The objective of the study will help de...
Eligibility Criteria
Inclusion
- Diagnosis of pseudohypoparathyroidism 1a
- Any body weight
Exclusion
- Absence of above diagnosis
Key Trial Info
Start Date :
June 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 20 2017
Estimated Enrollment :
519 Patients enrolled
Trial Details
Trial ID
NCT01398774
Start Date
June 1 2011
End Date
November 20 2017
Last Update
August 22 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States, 19104